Category: Investor updates

Imagion Biosystems Limited has lodged Appendix 4G “Key to Disclosures, Corporate Governance Council Principles and Recommendations” with the Australian Securities Exchange. Read Appendix 4G and

Imagion Biosystems is pleased to present the Company’s annual report for the year ending 31 December 2017. Read the 2017 Annual Report to Shareholders.

The purpose of this Audit and Risk Committee Charter is to formalise in accordance with the Constitution of Imagion Biosystems Limited (Company) the authority delegated

Imagion Biosystems Limited (Company) is committed to the objective of promoting investor confidence and the rights of shareholders. Read the Imagion Biosystems Limited Disclosure and

Imagion Biosystems Limited (Company) is committed to establishing a sound system of risk oversight and management and internal control to identify, assess, monitor and manage

Imagion Biosystems Limited Appendix 4E for the year ended 31 December 2017 has been lodged with ASX under Listing Rule 4.3A. Download FY 2017 Appendix

Imagion Biosystems today announced “Notice of change of interests of substantial holder — IBX.” View Form 604 Notice of change of interests of substantial holder —